The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study

Journal of Psychiatric Research

Volumn 46, Issue 2, 2012, Pages 219-225

  Bares, Martin ^a,b   Novak, Tomas ^a,b   Brunovsky, Martin ^a,b   Kopecek, Miloslav ^a,b   Stopkova, Pavla ^a,b   Krajca, Vladimir ^c   Höschl, Cyril ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CZECH TECHNICAL UNIVERSITY IN PRAGUE   (Czech Republic)

Author keywords

Bipolar depression; EEG cordance; Prediction; Response to treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; DIAZEPAM; ESCITALOPRAM; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; OLANZAPINE; QUETIAPINE; SERTRALINE; VALPROIC ACID; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PATIENT MONITORING; PILOT STUDY; PREDICTION; PREFRONTAL THETA CORDANCE; PRIORITY JOURNAL; QUANTITATIVE ELECTROENCEPHALOGRAM; THETA RHYTHM; TREATMENT RESPONSE; YOUNG MANIA RATING SCALE;

EID: 84856003866     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.09.006     Document Type: Article

References (79)

1. Altshuler L.L., Suppes T., Black D.O., Nolen W.A., Leverich G., Keck P.E., et al. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. American Journal of Psychiatry 2006, 163:313-315.
2. Diagnostic and statistical manual of mental disorders 2004, American Psychiatric Association, American Psychiatric Press, Washington DC. 4th ed.
3. Angst J., Sellaro R. Historical perspective and natural history of bipolar disorders. Biological Psychiatry 2000, 48:445-457.
4. Asada H., Fukuda Y., Tsunoda S., Yamaguchi M., Tonoike M. Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neuroscience Letters 1999, 274:29-32.
5. Backlund L., Ehnvall A., Hetta J., Isacsson G., Agren H. Identifying predictors for good lithium response - a retrospective analysis of 100 patients with bipolar disorder using a life-charting method. European Psychiatry 2009, 24:171-177.
6. Bares M., Brunovsky M., Kopecek M., Novak T., Stopkova P., Kozeny J., et al. Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. European Psychiatry 2008, 23:350-355.
7. Bares M., Brunovsky M., Kopecek M., Stopkova P., Novak T., Kozeny J., et al. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. Journal of Psychiatric Research 2007, 41:319-325.
8. Bares M., Brunovsky M., Novak T., Kopecek M., Stopkova P., Sos P., et al. The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. European Neuropsychopharmacol 2010, 20:459-466.
9. Bauer M., London E.D., Rasgon N., Berman S.M., Frye M.A., Altshuler L.L., et al. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Molecular Psychiatry 2005, 10:456-469.
10. Beck A.T., Rial W.Y., Rickels K. Short form of depression inventory: cross-validation. Psychological Report 1974, 34:1184-1186.
11. Brooks J., Po W.W., Ketter T. Functional brain imaging studies in bipolar disorder: Focus on cerebral metebolism and blood flow. Bipolar disorder 2010, 200-209. Wiley -Blackwell, Chichester. L.N. Yatham, M. Maj (Eds.).
12. Brooks J.O., Wang P.W., Bonner J.C., Rosen A.C., Hoblyn J.C., Hill S.J., et al. Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. Journal of Psychiatric Research 2009, 43:181-188.
13. Brooks J.O., Rosen A.C., Hoblyn J.C., Woodard S.A., Krasnykh O., Ketter T.A. Resting prefrontal hypometabolism and paralimbic hypermetabolism related to verbal recall deficits in euthymic older adults with bipolar disorder. American Journal of Geriatric Psychiatry 2009, 17:1022-1029.
14. Calabrese J.R., Vieta E., El-Mallakh R., Findling R.L., Youngstrom E.A., Elhaj O., et al. Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biological Psychiatry 2004, 56:957-963.
15. Cook I.A. Biomarkers in psychiatry: potentials, pitfalls, and pragmatics. Primary Psychiatry 2008, 15:54-59.
16. Cook I.A., Hunter A.M., Abrams M., Siegman B., Leuchter A.F. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Research 2009, 174:152-157.
17. Cook I.A., Leuchter A.F., Morgan M., Witte E., Stubbeman W.F., Abrams M., et al. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 2002, 27:120-131.
18. Cook I.A., Leuchter A.F., Morgan M.L., Stubbeman W., Siegman B., Abrams M. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. Journal of Psychiatric Research 2005, 39:461-466.
19. Cook I.A., O'Hara R., Uijtdehaage S.H., Mandelkern M., Leuchter A.F. Assessing the accuracy of topographic EEG mapping for determining local brain function. Electroencephalography and Clinical Neurophysiology 1998, 107:408-414.
20. Culha A.F., Osman O., Dogangun Y., Filiz K., Suna K., Kalkan O.N., et al. Changes in regional cerebral blood flow demonstrated by 99mTc-HMPAO SPECT in euthymic bipolar patients. European Archives of Psychiatry and Clinical Neuroscience 2008, 258:144-151.
21. Drevets W.C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annual Reviews of Medicine 1998, 49:341-361.
22. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function 2008, 213:93-118.
23. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
24. Drevets W.C., Savitz J., Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectrum 2008, 13:663-681.
25. Dunn R.T., Kimbrell T.A., Ketter T.A., Frye M.A., Willis M.W., Luckenbaugh D.A., et al. Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biological Psychiatry 2002, 51:387-399.
26. Fountoulakis K.N., Grunze H., Panagiotidis P., Kaprinis G. Treatment of bipolar depression: an update. Journal of Affective Disorders 2008, 109:21-34.
27. Goldberg J.F., Perlis R.H., Ghaemi S.N., Calabrese J.R., Bowden C.L., Wisniewski S., et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. American Journal of Psychiatry 2007, 164:1348-1355.
28. Goodwin G.M., Anderson I., Arango C., Bowden C.L., Henry C., Mitchell P.B., Nolen W.A., Vieta E., Wittchen H.U. ECNP consensus meeting. Bipolar depression. Nice, March 2007. European Neuropsychopharmacology 2008, 18:535-549.
29. Grof P., Alda M., Grof E., Zvolsky P., Walsh M. Lithium response and genetics of affective disorders. Journal of Affective Disorders 1994, 32:85-95.
30. Grof P., Duffy A., Cavazzoni P., Grof E., Garnham J., MacDougall M., et al. Is response to prophylactic lithium a familial trait?. Journal of Clinical Psychiatry 2002, 63:942-947.
31. Grunze H., Vieta E., Goodwin G.M., Bowden C., Licht R.W., Moller H.J., et al. The World Federation of Societies of Biological psychiatry (WFSBP) guidelines for the Biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World Journal of Biological Psychiatry 2010, 11:81-109.
32. Guy W. ECDU assessment manual for psychopharmacology-revised 1976, US Dept. Health, Education and Welfare Publication (ADM) 76-338, Rockville, MD, p. 218.
33. Haldane M., Frangou S. Functional neuroimaging studies in mood disorders. Acta Neuropsychiatrica 2006, 18:88-99.
34. Hirschfeld R.M. Bipolar depression: the real challenge. European Neuropsychopharmacology 2004, 14(2):S83-S88.
35. Hjorth B. An on-line transformation of EEG scalp potentials into orthogonal source derivations. Electroencephalography and Clinical Neurophysiology 1975, 39:526-530.
36. Horacek J., Brunovsky M., Novak T., Tislerova B., Palenicek T., Bubenikova-Valesova V., et al. Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect. Psychological Medicine 2010, 40:1443-1451.
37. Hosokawa T., Momose T., Kasai K. Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33:243-250.
38. Johnson S.L., Cuellar A.K., Ruggero C., Winett-Perlman C., Goodnick P., White R., et al. Life events as predictors of mania and depression in bipolar I disorder. Journal of Abnormal Psychology 2008, 117:268-277.
39. Judd L.L., Akiskal H.S., Schettler P.J., Endicott J., Leon A.C., Solomon D.A., et al. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Archives of General Psychiatry 2005, 62:1322-1330.
40. Judd L.L., Akiskal H.S., Schettler P.J., Endicott J., Maser J., Solomon D.A., et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 2002, 59:530-537.
41. Ketter T.A., Wang P.W. Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies. Journal of Clinical Psychiatry 2002, 63(3):21-25.
42. Ketter T.A., Drevets W.C. Neuroimaging studies of bipolar depression: functional neuropathology, treatment effects, and predictors of clinical response. Clinical Neuroscience Research 2002, 2:182-192.
43. Ketter T.A., Kimbrell T.A., George M.S., Dunn R.T., Speer A.M., Benson B.E., et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biological Psychiatry 2001, 49:97-109.
44. Kobak K.A., Greist J.H., Jefferson J.W., Katzelnick D.J. Computer-administered clinical rating scales. A review. Psychopharmacology (Berl) 1996, 127:291-301.
45. Kopecek M., Sos P., Brunovsky M., Bares M., Stopkova P., Krajca V. Can prefrontal theta cordance differentiate between depression recovery and dissimulation?. Neuroendcrinological Letters 2007, 28:524-526.
46. Kopecek M., Tislerova B., Sos P., Bares M., Novak T., Krajca V., et al. QEEG changes during switch from depression to hypomania/mania: a case report. Neuroendcrinological Letters 2008, 29:295-302.
47. Kupka R.W., Altshuler L.L., Nolen W.A., Suppes T., Luckenbaugh D.A., Leverich G.S., et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disorders 2007, 9:531-535.
48. Leuchter A.F., Cook I.A., DeBrota D.J., Hunter A.M., Potter W.Z., McGrouther C.C., et al. Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clinical EEG and Neuroscience 2008, 39:175-181.
49. Leuchter A.F., Cook I.A., Hamilton S.P., Narr K.L., Toga A., Hunter A.M., et al. Biomarkers to predict antidepressant response. Current Psychiatry Reports 2010, 12:553-562.
50. Leuchter A.F., Cook I.A., Lufkin R.B., Dunkin J., Newton T.F., Cummings J.L., et al. Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage 1994, 1:208-219.
51. Leuchter A.F., Cook I.A., Mena I., Dunkin J.J., Cummings J.L., Newton T.F., et al. Assessment of cerebral perfusion using quantitative EEG cordance. Psychiatry Research 1994, 55:141-152.
52. Leuchter A.F., Cook I.A., Witte E.A., Morgan M., Abrams M. Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry 2002, 159:122-129.
53. Leuchter A.F., Uijtdehaage S.H., Cook I.A., O'Hara R., Mandelkern M. Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Research 1999, 90:125-140.
54. Lyoo I.K., Dager S.R., Kim J.E., Yoon S.J., Friedman S.D., Dunner D.L., et al. Lithium-Induced Gray Matter volume increase as a Neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology 2010, 35:1743-1750.
55. Mah L., Zarate C.A., Singh J., Duan Y.F., Luckenbaugh D.A., Manji H.K., et al. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biological Psychiatry 2007, 61:765-775.
56. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997, 8:1057-1061.
57. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 2000, 48:830-843.
58. Merikangas K.R., Akiskal H.S., Angst J., Greenberg P.E., Hirschfeld R.M., Petukhova M., et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Archives of General Psychiatry 2007, 64:543-552.
59. Mitchell P.B., Malhi G.S. Bipolar depression: phenomenological overview and clinical characteristics. Bipolar Disorders 2004, 6:530-539.
60. Moller H.J., Grunze H., Broich K. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. European Archives of Psychiatry and Clinical Neuroscience 2006, 256:1-16.
61. Montgomery S.A., åsberg M. Anew depression scale designed to be sensitive to change. British Journal of Psychiatry 1979, 134:382-389.
62. Mulert C., Juckel G., Brunnmeier M., Karch S., Leicht G., Mergl R., et al. Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication. Clinical EEG and Neuroscience 2007, 38:78-81.
63. Nierenberg A.A., Ostacher M.J., Calabrese J.R., Ketter T.A., Marangell L.B., Miklowitz D.J., et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. American Journal of Psychiatry 2006, 163:210-216.
64. Nivoli A.M., Colom F., Murru A., Pacchiarotti I., Castro-Loli P., Gonzalez-Pinto A., et al. New treatment guidelines for acute bipolar depression: a systematic review. Journal of Affective Disorders 2010, 129:14-26.
65. Nuwer M.R., Lehmann D., da Silva F.L., Matsuoka S., Sutherling W., Vibert J.F. IFCN guidelines for topographic and frequency analysis of EEGs and EPs.The International Federation of clinical Neurophysiology. Electroencephalography and Clinical Neurophysiology 1999, 52:15-20.
66. Pizzagalli D.A., Oakes T.R., Davidson R.J. Coupling of theta activity and glucose metabolism in the human rostral anterior cingulate cortex: an EEG/PET study of normal and depressed subjects. Psychophysiology 2003, 40:939-949.
67. Post R.M., Denicoff K.D., Leverich G.S., Altshuler L.L., Frye M.A., Suppes T.M., et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. Journal of Clinical Psychiatry 2003, 64:680-690.
68. Sachs G.S., Nierenberg A.A., Calabrese J.R., Marangell L.B., Wisniewski S.R., Gyulai L., et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine 2007, 356:1711-1722.
69. Salvi V., Fagiolini A., Swartz H.A., Maina G., Frank E. The use of antidepressants in bipolar disorder. Journal of Clinical Psychiatry 2008, 69:1307-1318.
70. Savitz J., Drevets W.C. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neuroscience & Biobehavioral Reviews 2009, 33:699-771.
71. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59(20):22-33.
72. Strakowski S.M., Delbello M.P., Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular Psychiatry 2005, 10:105-116.
73. Thase M.E., Macfadden W., Weisler R.H., Chang W., Paulsson B., Khan A., et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). Journal of Clinical Psychopharmacology 2006, 26:600-609.
74. Tohen M., Vieta E., Calabrese J., Ketter T.A., Sachs G., Bowden C., et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry 2003, 60:1079-1088.
75. Tondo L., Vazquez G., Baldessarini R.J. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatrica Scandinavica 2010, 121:404-414.
76. Treuer T., Tohen M. Predicting the course and outcome of bipolar disorder: a review. European Psychiatry 2010, 25:328-333.
77. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S.V., MacQueen G., McIntyre R.S., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disorders 2006, 8:721-739.
78. Yatham L.N., Kennedy S.H., Schaffer A., Parikh S.V., Beaulieu S., O'Donovan C., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders 2009, 11:225-255.
79. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. Arating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 1978, 133:429-435.